Papers
4
Total Citations
112
H-Index
4
About
Dr. C. Pettenati is a leading French urologic oncologist whose research focuses on the surgical and clinical management of kidney cancer. Their most significant contributions lie in advancing evidence-based guidelines for renal cell carcinoma and refining surgical approaches to nephrectomy. As a key author of the French AFU Cancer Committee Guidelines for kidney cancer (2022–2024 and 2024–2026 updates), Dr. Pettenati has helped shape national standards for diagnosis, surgical treatment, and medical management, with these influential documents accumulating over 60 citations. Their landmark UroCCR-47 study (2022, 46 citations) directly addressed an unmet clinical need by comparing robotic-assisted partial nephrectomy (RPN) with open partial nephrectomy (OPN) using contemporary multicentric data from 20 centers. This work provided crucial real-world evidence on outcomes, helping surgeons and patients make informed decisions about minimally invasive versus open approaches. Dr. Pettenati’s research bridges the gap between large-scale registry data and practical surgical decision-making, making them a pivotal figure in modern kidney cancer care. Their ongoing contributions to guideline updates ensure that French and international urologists have access to the latest evidence-based recommendations.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4